|
|
|
Volumn 17, Issue 2-3, 1998, Pages 59-60
|
|
The withdrawal of mibefradil (Posicor)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIARRHYTHMIC AGENT;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ESTROGEN;
FELODIPINE;
GLYCERYL TRINITRATE;
METOPROLOL;
MIBEFRADIL;
NEUROLEPTIC AGENT;
NITRATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SIMVASTATIN;
TIMOLOL;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADVERSE DRUG REACTION;
ANGINA PECTORIS;
CARDIOGENIC SHOCK;
DRUG COST;
DRUG MONITORING;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDITORIAL;
HYPERTENSION;
ORAL DRUG ADMINISTRATION;
SUBLINGUAL DRUG ADMINISTRATION;
BENZIMIDAZOLES;
CALCIUM CHANNEL BLOCKERS;
DRUG AND NARCOTIC CONTROL;
DRUG INTERACTIONS;
HUMANS;
MIBEFRADIL;
PRODUCT SURVEILLANCE, POSTMARKETING;
TETRAHYDRONAPHTHALENES;
|
|
EID: 0031768773
PISSN: 0964198X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (9)
|
|
References (1)
|